Uncertainty Principle
A disgraced Ranbaxy has a long and expensive journey ahead before it regains the trust of global and Indian customers. By E. Kumar Sharma and Chaitanya Kalbag Two inspectors working for the US Food and Drug Administration (FDA), on a trip to a Ranbaxy Laboratories factory late in January 2008, were stunned by what they…












